![](/img/cover-not-exists.png)
PCN72 COST-EFFECTIVENESS OF LETROZOLE AND OF ANASTROZOLE VERSUS TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER USING UPDATED SURVIVAL DATA FROM THE BIG 1–98 AND ATAC TRIALS:A UK PERSPECTIVE
J Karnon, S KauraVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)71967-2
File:
PDF, 76 KB
english, 2010